Page 8 - குணப்படுத்த ஆரோக்கியம் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MINDCURE Completes Its Initial Strategic Equity Investment in ATMA, Canada s First Commercial Provider of Legal, Psychedelic-Assisted, Therapy Utilizing Psilocybin

MINDCURE Completes Its Initial Strategic Equity Investment in ATMA, Canada s First Commercial Provider of Legal, Psychedelic-Assisted, Therapy Utilizing Psilocybin
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

United statesBritish columbiaGreg habstrittKelsey ramsdenGovernment of canada healthCompany codesJourney centers incHealth canadaCure health incCure healthJourney centersUnited states securities actஒன்றுபட்டது மாநிலங்களில்பிரிட்டிஷ் கொலம்பியாகெல்ஸீ ராம்ஸ்டன்அரசு ஆஃப் கனடா ஆரோக்கியம்

MINDCURE Completes Its Initial Strategic Equity Investment in ATMA, Canada s First Commercial Provider of Legal, Psychedelic-Assisted, Therapy Utilizing Psilocybin

Share this article The completed equity investment strengthens ties between MINDCURE and ATMA VANCOUVER, BC, March 2, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ( MINDCURE or the Company ), a leader in developing technology to advance psychedelic-related treatments, is pleased to announce the completion of its initial strategic equity investment of equal to approximately 13% ownership in ATMA Journey Centers Inc. ( ATMA ) in accordance with the terms of the letter of intent (the LOI ) announced on January 12, 2021. MINDCURE s initial strategic investment of $500,000 will strengthen our relationship with Calgary-based private healthcare company, ATMA, which has recently provided psychedelic-assisted therapy sessions using psilocybin for patients with section 56 exemptions.

United statesBritish columbiaGreg habstrittKelsey ramsdenGovernment of canada healthJourney centers incHealth canadaCure health incCure healthJourney centersUnited states securities actMind cure health incஒன்றுபட்டது மாநிலங்களில்பிரிட்டிஷ் கொலம்பியாகெல்ஸீ ராம்ஸ்டன்அரசு ஆஃப் கனடா ஆரோக்கியம்

MINDCURE Completes Its Initial Strategic Equity Investment in ATMA, Canada s First Commercial Provider of Legal, Psychedelic-Assisted, Therapy Utilizing Psilocybin

MINDCURE Completes Its Initial Strategic Equity Investment in ATMA, Canada s First Commercial Provider of Legal, Psychedelic-Assisted, Therapy Utilizing Psilocybin
newswire.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswire.ca Daily Mail and Mail on Sunday newspapers.

United statesBritish columbiaGreg habstrittJonathanl robinsonKelsey ramsdenGovernment of canada healthJourney centers incHealth canadaCure health incOak hill financial incCure healthJourney centersUnited states securities actInvestor relationsஒன்றுபட்டது மாநிலங்களில்பிரிட்டிஷ் கொலம்பியா

MCURF Stock Price, Mind Cure Health Stock Quotes and News

Mind Cure Health (Mind Cure Health: MCURF) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers.

Cure health incMind cure health incகுணப்படுத்த ஆரோக்கியம் இன்க்மனம் குணப்படுத்த ஆரோக்கியம் இன்க்

Apple (AAPL), Mind Cure Health (MCURF) - The Digital Therapeutics Market Is Redefining Psychedelic Research And Patient Care

The following article is sponsored by Mind Cure. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for informational purposes only. Digital therapeutics (DTx) are a form of patient care that are gaining momentum in the medical industry and the effects of the pandemic have only accelerated this growth. In 2019, Insider Intelligence projected that the digital therapeutics industry would reach a market value of $9 billion by 2025. Although last year, their projections increased dramatically with the market value of DTx expected to hit nearly $56 billion in the next five years.

David keeneGeoff belairDigital health software precertification programPsychedelic companiesLife sciencesApple incCure health incInsider intelligenceMind cure health incMind cureIntrospect digitalRegulatory landscapeBreakthrough designationடேவிட் கீந்ஜியோஃப் பேழைற்சைகடெலிக் நிறுவனங்கள்